Vitreoretinal Department, Moorfields Eye Hospital, City Road, London EC1V2PD, UK.
Invest Ophthalmol Vis Sci. 2012 Jul 24;53(8):4889-96. doi: 10.1167/iovs.12-9874.
To describe the genotype-phenotype relationship of a cohort of consecutive patients with isolated ectopia lentis (EL) secondary to ADAMTSL4 and FBN1 mutations.
Patients underwent detailed ocular, cardiovascular, and skeletal examination. This was correlated with Sanger sequencing of ADAMTSL4 and FBN1 genes.
Seventeen patients were examined, including one with ectopia lentis et pupillae. Echocardiography and skeletal examination revealed no sign of systemic disorders associated with EL, in particular Marfan syndrome (MFS). Nine patients (52.9%) were found to have mutations in ADAMTSL4, including four novel nonsense mutations. Four patients (25%) were found to have novel FBN1 mutations, not previously reported as causing classical Marfan syndrome. One additional patient was found to have an FBN1 mutation previously reported in classical MFS. Four patients (25%) were found to have no mutations in either gene. Median age of diagnosis of EL was 35 years in patients with FBN1 mutations and 2 years in patients with ADAMTSL4 mutations (P < 0.01). Mean axial length was 22.74 mm (95% confidence interval [CI]: 21.3-24.2) (FBN1) and 27.54 mm (95% CI: 24.2-30.9) (ADAMTSL4) (P < 0.01). Other ophthalmic features, including corneal thickness and power, foveal thickness, visual acuity, and direction of lens displacement, were similar for both groups.
ADAMTSL4 is the most important known causative gene in isolated EL. Mutations in ADAMTSL4 appear to cause earlier manifestation of EL and are associated with increased axial length as compared to FBN1. We suggest that ADAMTSL4 be screened in all patients with isolated EL and that physicians be vigilant for the more severe ocular phenotype associated with mutations in this gene.
描述一组连续的、由 ADAMTSL4 和 FBN1 基因突变引起的单纯性晶状体异位(EL)患者的基因型-表型关系。
患者接受详细的眼部、心血管和骨骼检查。这与 ADAMTSL4 和 FBN1 基因的 Sanger 测序相关联。
共检查了 17 名患者,其中 1 名患有晶状体异位伴瞳孔。超声心动图和骨骼检查未发现与 EL 相关的系统性疾病的迹象,特别是马凡综合征(MFS)。发现 9 名患者(52.9%)存在 ADAMTSL4 基因突变,包括 4 种新的无意义突变。发现 4 名患者(25%)存在新的 FBN1 突变,这些突变以前没有报道过导致经典马凡综合征。另外 1 名患者存在以前报道过的经典 MFS 的 FBN1 突变。在这 17 名患者中,有 4 名患者(25%)在这两个基因中均未发现突变。FBN1 基因突变患者的 EL 诊断中位年龄为 35 岁,ADAMTSL4 基因突变患者为 2 岁(P < 0.01)。FBN1 组的平均眼轴长度为 22.74mm(95%置信区间[CI]:21.3-24.2),ADAMTSL4 组为 27.54mm(95%CI:24.2-30.9)(P < 0.01)。两组的其他眼部特征,包括角膜厚度和屈光力、黄斑中心凹厚度、视力和晶状体移位方向,均相似。
ADAMTSL4 是已知的引起单纯性 EL 的最重要的致病基因。与 FBN1 相比,ADAMTSL4 基因突变似乎导致 EL 更早出现,并与眼轴长度增加相关。我们建议对所有单纯性 EL 患者进行 ADAMTSL4 筛查,并警惕与该基因突变相关的更严重的眼部表型。